Buscar
Mostrando ítems 1-10 de 21
Preprint
Low rate of relapse after twelve-dose multidrug therapy for hansen’s disease: A 20-year cohort study in a brazilian reference center
| Fecha del documento:
2021 | Derechos de autor:
open access
Preprint
Anti-inflammatory effect of Schinus terebinthifolius Raddi hydroalcoholic extract on neutrophil migration in zymosan-induced arthritis
| Fecha del documento:
2015 | Derechos de autor:
open access
Preprint
Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way
| Fecha del documento:
2022 | Derechos de autor:
open access
Preprint
Cross-reactivity and immunotherapeutic potential of BamA recombinant protein from Acinetobacter baumannii
| Fecha del documento:
2021 | Derechos de autor:
open access
Preprint
The role of NSP6 in the biogenesis of the SARS-CoV-2 replication organelle
| Fecha del documento:
2022 | Derechos de autor:
open access
Preprint
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms - Short running title: Ebola SARS-CoV-2 inhibitors
| Fecha del documento:
2021 | Derechos de autor:
open access
Preprint
Non-permissive SARS-CoV-2 infection of neural cells in the developing human brain and neurospheres
| Fecha del documento:
2020 | Derechos de autor:
open access
Preprint
Non-permissive SARS-CoV-2 infection in human neurospheres (preprint)
| Fecha del documento:
2021 | Derechos de autor:
open access
Preprint
Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production
| Fecha del documento:
2020 | Derechos de autor:
open access
Preprint
The COVID-19 pandemics and the relevance of biosafety facilities for metagenomics surveillance, structured disease prevention and control
| Fecha del documento:
2020 | Derechos de autor:
open access